Soluble DPP4 originates in part from bone marrow cells and not from the kidney

Peptides

Volumn 57, Issue , 2014, Pages 109-117

  Wang, Zhendi ^a,b   Grigo, Christina ^a   Steinbeck, Julia ^a   Von Hörsten, Stephan ^a   Amann, Kerstin ^a   Daniel, Christoph ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bone marrow; CD26; DPP4 deficient rat; Kidney transplantation; Soluble DPP4

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; SOLUBLE DIPEPTIDYL PEPTIDASE IV; UNCLASSIFIED DRUG; CHEMOKINE; INCRETIN; NEUROPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BRAIN; CELL SUBPOPULATION; CONGENIC STRAIN; CONTROLLED STUDY; DARK AGOUTI RAT; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXTRACTION; FLOW CYTOMETRY; HEART; INTESTINE; KIDNEY; KIDNEY TRANSPLANTATION; LEUKOCYTE; LIVER; LUNG; LYMPHOCYTE COUNT; MACROPHAGE; MALE; NONHUMAN; PANCREAS; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SKELETAL MUSCLE; SKIN; SPLEEN; THYMUS; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; METABOLISM; SOLUBILITY;

AGOUTI; RATTUS;

ANIMALS; BONE MARROW CELLS; CHEMOKINES; DIPEPTIDYL PEPTIDASE 4; INCRETINS; KIDNEY; KIDNEY TRANSPLANTATION; LEUKOCYTES; MACROPHAGES; NEUROPEPTIDES; RATS; SOLUBILITY;

EID: 84902552092     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.05.006     Document Type: Article

References (39)

1. T. Andrieu, V. Thibault, I. Malet, J. Laporte, B. Bauvois, and H. Agut et al. Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections J Clin Virol 27 2003 59 68
2. F. Bermpohl, K. Loster, W. Reutter, and O. Baum Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens FEBS Lett 428 1998 152 156
3. O.J. Cordero, M. Imbernon, L.D. Chiara, V.S. Martinez-Zorzano, D. Ayude, and M.P. de la Cadena et al. Potential of soluble CD26 as a serum marker for colorectal cancer detection World J Clin Oncol 2 2011 245 261
4. O.J. Cordero, F.J. Salgado, and M. Nogueira On the origin of serum CD26 and its altered concentration in cancer patients Cancer Immunol Immunother 58 2009 1723 1747
5. C. Daniel, A. Ludke, A. Wagner, V.T. Todorov, B. Hohenstein, and C. Hugo Transgelin is a marker of repopulating mesangial cells after injury and promotes their proliferation and migration Lab Invest 92 2012 812 826
6. I. de Meester, A.M. Lambeir, P. Proost, and S. Scharpe Dipeptidyl peptidase IV substrates. An update on in vitro peptide hydrolysis by human DPPIV Adv Exp Med Biol 524 2003 3 17
7. N. Frerker, K. Raber, F. Bode, T. Skripuletz, H. Nave, and C. Klemann et al. Phenotyping of congenic dipeptidyl peptidase 4 (DP4) deficient Dark Agouti (DA) rats suggests involvement of DP4 in neuro-, endocrine, and immune functions Clin Chem Lab Med 47 2009 275 287
8. B. Gallwitz New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins Rev Diabet Stud 2 2005 61 69
9. M.D. Gorrell, V. Gysbers, and G.W. McCaughan CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes Scand J Immunol 54 2001 249 264
10. H. Gotoh, M. Hagihara, T. Nagatsu, H. Iwata, and T. Miura Activity of dipeptidyl peptidase IV and post-proline cleaving enzyme in sera from osteoporotic patients Clin Chem 34 1988 2499 2501
11. G. Grondin, N.M. Hooper, and D. LeBel Specific localization of membrane dipeptidase and dipeptidyl peptidase IV in secretion granules of two different pancreatic islet cells J Histochem Cytochem 47 1999 489 498
12. M. Hagihara, M. Ohhashi, and T. Nagatsu Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis Clin Chem 33 1987 1463 1465
13. C. Hanski, T. Zimmer, R. Gossrau, and W. Reutter Increased activity of dipeptidyl peptidase IV in serum of hepatoma-bearing rats coincides with the loss of the enzyme from the hepatoma plasma membrane Experientia 42 1986 826 828
14. S. Hartel, C. Hanski, R. Neumeier, R. Gossrau, and W. Reutter Characterization of different forms of dipeptidyl peptidase IV from rat liver and hepatoma by monoclonal antibodies Adv Exp Med Biol 240 1988 207 214
15. M. Hildebrandt, W. Reutter, and J.D. Gitlin Tissue-specific regulation of dipeptidyl peptidase IV expression during development Biochem J 277 Pt 2 1991 331 334
16. S. Iwaki-Egawa, Y. Watanabe, Y. Kikuya, and Y. Fujimoto Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence J Biochem 124 1998 428 433
17. S. Iwata, and C. Morimoto CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation J Exp Med 190 1999 301 306
18. R.J. Johnson, P. Pritzl, H. Iida, and C.E. Alpers Platelet-complement interactions in mesangial proliferative nephritis in the rat Am J Pathol 138 1991 313 321
19. Y. Kasahara, G. Leroux-Roels, R. Nakamura, and F. Chisari Glycylprolyl-diaminopeptidase in human leukocytes: selective occurrence in T lymphocytes and influence on the total serum enzyme activity Clin Chim Acta 139 1984 295 302
20. S. Korom, I. De Meester, K. Onodera, T.H. Stadlbauer, M. Borloo, and A.M. Lambeir et al. The effects of CD26/DPP IV-targeted therapy on acute allograft rejection Transpl Proc 29 1997 1274 1275
21. E. Krepela, E. Kasafirek, J. Vicar, and J. Kraml An assay of dipeptidyl peptidase IV activity in human serum and serum of pregnant women with glycyl-l-proline-1-naphthylamide and other glycyl-l-proline-arylamides as substrates Physiol Bohemoslov 32 1983 334 345
22. C. Kruschinski, T. Skripuletz, S. Bedoui, T. Tschernig, R. Pabst, and C. Nassenstein et al. CD26 (dipeptidyl-peptidase IV)-dependent recruitment of T cells in a rat asthma model Clin Exp Immunol 139 2005 17 24
23. A.M. Lambeir, C. Durinx, P. Proost, J. Van Damme, S. Scharpe, and I. De Meester Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion FEBS Lett 507 2001 327 330
24. Z. Lojda Studies on dipeptidyl(amino)peptidase IV (glycyl-proline naphthylamidase). II. Blood vessels Histochemistry 59 1979 153 166
25. R. Mentlein, F. Schiemann, A. Ludwig, and E. Brandt Modification of the biological activity of chemokines by dipeptidyl peptidase IV - a side effect in the use of inhibitors Adv Exp Med Biol 524 2003 37 47
26. S. Mentzel, H.B. Dijkman, J.P. Van Son, R.A. Koene, and K.J. Assmann Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice J Histochem Cytochem 44 1996 445 461
27. C. Morimoto, and S.F. Schlossman The structure and function of CD26 in the T-cell immune response Immunol Rev 161 1998 55 70
28. K. Ohnuma, O. Hosono, N.H. Dang, and C. Morimoto Dipeptidyl peptidase in autoimmune pathophysiology Adv Clin Chem 53 2011 51 84
29. F. Perner, T. Gyuris, G. Rakoczy, E. Sarvary, D. Gorog, and F. Szalay et al. Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence J Lab Clin Med 134 1999 56 67
30. M.D. Poulsen, G.H. Hansen, E. Dabelsteen, P.E. Hoyer, O. Noren, and H. Sjostrom Dipeptidyl peptidase IV is sorted to the secretory granules in pancreatic islet A-cells J Histochem Cytochem 41 1993 81 88
31. A. Sedo, J.S. Duke-Cohan, E. Balaziova, and L.R. Sedova Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis Arthritis Res Ther 7 2005 253 269
32. A. Sedo, J. Stremenova, P. Busek, and J.S. Duke-Cohan Dipeptidyl peptidase-IV and related molecules: markers of malignancy Expert Opin Med Diagn 2 2008 677 689
33. K. Shingu, A. Helfritz, S. Kuhlmann, M. Zielinska-Skowronek, R. Jacobs, and R.E. Schmidt et al. Kinetics of the early recruitment of leukocyte subsets at the sites of tumor cells in the lungs: natural killer (NK) cells rapidly attract monocytes but not lymphocytes in the surveillance of micrometastasis Int J Cancer 99 2002 74 81
34. K. Shingu, A. Helfritz, M. Zielinska-Skowronek, D. Meyer-Olson, R. Jacobs, and R.E. Schmidt et al. CD26 expression determines lung metastasis in mutant F344 rats: involvement of NK cell function and soluble CD26 Cancer Immunol Immunother 52 2003 546 554
35. N.J. Topham, and E.W. Hewitt Natural killer cell cytotoxicity: how do they pull the trigger Immunology 128 2009 7 15
36. T. Uematsu, H. Tanaka, M. Yamaoka, and K. Furusawa Effects of oral squamous cell carcinoma-derived TGF-beta1 on CD26/DPPIV expression in T cells Anticancer Res 24 2004 619 624
37. T. Uematsu, M. Urade, and M. Yamaoka Decreased expression and release of dipeptidyl peptidase IV (CD26) in cultured peripheral blood T lymphocytes of oral cancer patients J Oral Pathol Med 27 1998 106 110
38. R. Vogelbacher, S. Meister, E. Guckel, C. Starke, S. Wittmann, and A. Stief et al. Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat Nephrol Dial Transplant 25 2010 3764 3773
39. R. Yazbeck, M.L. Sulda, G.S. Howarth, A. Bleich, K. Raber, and S. von Horsten et al. Dipeptidyl peptidase expression during experimental colitis in mice Inflamm Bowel Dis 16 2010 1340 1351